Researchers revealed that, people who consume drugs are usually used to treat heartburn, ulcers and other gastrointestinal difficulties for an extended time may be at an augmented risk of death. The study further demonstrated that people consuming these drugs called as proton pump inhibitors (PPIs) had a 50 per cent augmented risk of dying over the subsequently five years.
Ziyad Al-Aly, Assistant Professor at the Washington University School of Medicine in St. Louis has also further conveyed that, people have the idea that PPIs are secure because they are eagerly accessible, but there are risks consuming these drugs, mainly for long periods of time.
Moreover, for every 500 people taking PPIs for a year, there was one extra death that would not have otherwise happened. Al-Aly has also further conveyed that, people who constantly take PPIs, this could interpret into thousands of excess deaths each year.
PPIs have also been associated to a variety of health difficulties, counting serious kidney damage, bone fractures and dementia. The researchers examined medical records of some 275,000 users of PPIs and almost 75,000 people who took another class of drugs — known as H2 blockers — to lessen stomach acid. Mutually PPIs and H2 blockers are set for solemn medical conditions such as upper gastrointestinal tract bleeding, gastro esophageal reflux disease and esophageal cancer.